Ribbon Blender Model 42N-270 Increases Performance - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ribbon Blender Model 42N-270 Increases Performance


Pharmaceutical Technology
Volume 38, Issue 1, pp. 16
The Ribbon Blender Model 42N-270 has a maximum working capacity of 270 cu.ft. and a full holding capacity of 300 cu.ft. The stainless steel wetted parts are polished to 150-grit finish for cleanability. The gasketed three-piece cover, safety grating, and pneumatically-operated 10” knife gate valve are all designed to facilitate ingredient charging and dust-tight operation. The double ribbon agitator is fabricated to produce a well-balanced axial and radial flow of powders while holding tightly-controlled clearances between the trough. The solid agitator shaft is driven to 20 rpm by a 100 HP TEFC motor.  All Ross Ribbon Blenders are equipped with a direct drive gear motor for improved performance and lower maintenance. With Ross-supplied controls, users receive a production-ready blender and benefit from electronic speed control, soft-start capabilities, and overload protection without any wiring hassles.

Charles Ross & Son Company

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here